(Invited) A FDA Staff Perspective on Navigating the Regulatory Landscape and Moving Medical Devices to the Marketplace

Tuesday, 3 October 2017: 10:00
National Harbor 11 (Gaylord National Resort and Convention Center)
K. Wachrathit (US FDA, CDRH, Office of Device Evaluation)

The United States Food and Drug Administration (FDA) ensures that patients in the U.S. have access to safe and effective medical devices. The Division of Neurological and Physical Medicine Devices reviews medical devices that interface with the nervous system. This presentation will assist attendees in how to navigate the FDA’s regulatory landscape to successfully bring medical devices to patients.